{'fraction_non_alphanumeric': 0.01867572156196944, 'fraction_numerical': 0.006791171477079796, 'mean_word_length': 5.8604651162790695, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Alternative study designs show no link between antidepressant exposure, autism

Most studies examining the association between prenatal antidepressant exposure and autism risk do not adequately control for factors such as maternal depression, and alternative study designs call into question the association, a meta‐analysis has concluded. Two less commonly used, but more rigorous, study designs do not support an association between prenatal antidepressant exposure and autism, the meta‐analysis found. Results were published in the June 2020 issue of the American Journal of Psychiatry.